ArticleInternal medicine (Tokyo, Japan)2022

Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and Implications of New Biomarkers.

Hajime Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.